financetom
Business
financetom
/
Business
/
New Jersey Resources Swings to Loss in Fiscal Q3, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
New Jersey Resources Swings to Loss in Fiscal Q3, Revenue Rises
Aug 6, 2024 6:36 AM

09:00 AM EDT, 08/06/2024 (MT Newswires) -- New Jersey Resources ( NJR ) reported a fiscal Q3 net financial loss Tuesday of $0.09 per share, swinging from net financial earnings of $0.10 per share a year earlier.

Analysts surveyed by Capital IQ expected a normalized loss of $0.05 per share.

Revenue for the quarter ended June 30 was $275.6 million, compared with $264.1 million a year earlier.

One analyst surveyed by Capital IQ expected $284 million.

The company said it continues to expect fiscal 2024 net financial earnings per share of $2.85 to $3.00.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Figure Technology Solutions Q3 Earnings, Revenue Rise; Shares Up After Hours
Figure Technology Solutions Q3 Earnings, Revenue Rise; Shares Up After Hours
Nov 13, 2025
04:29 PM EST, 11/13/2025 (MT Newswires) -- Figure Technology Solutions ( FIGR ) reported fiscal Q3 earnings late Thursday of $0.34 a share, up from $0.09 a year earlier. Analysts polled by FactSet expected $0.16. Revenue in the three months ended Sept. 30 rose to $156.4 million from $101.0 million a year earlier. Analysts surveyed by FactSet expected $119.4 million....
Saab in talks with Canada, Bombardier to build Gripen fighter jets, Globe and Mail reports
Saab in talks with Canada, Bombardier to build Gripen fighter jets, Globe and Mail reports
Nov 13, 2025
Nov 13 (Reuters) - Swedish defense company Saab is in talks with the Canadian government and Bombardier to build its Gripen fighter jet under license in Canada, Chief Executive Officer Micael Johansson told the Globe and Mail on Thursday. ...
Blood purification firm CytoSorbents Q3 revenue misses estimates
Blood purification firm CytoSorbents Q3 revenue misses estimates
Nov 13, 2025
Overview * CytoSorbents Q3 2025 revenue rose 10% yr/yr to $9.5 mln, missing analyst expectations * Adjusted EPS for Q3 2025 beats analyst expectations * Company implements workforce reduction to accelerate cash-flow breakeven to Q1 2026 Outlook * CytoSorbents expects cash-flow breakeven by Q1 2026 * Company anticipates FDA decision on DrugSorb-ATR by mid-2026 Result Drivers * DISTRIBUTOR SALES -...
Acrivon Therapeutics Q3 net loss narrows to $18.2 mln
Acrivon Therapeutics Q3 net loss narrows to $18.2 mln
Nov 13, 2025
Overview * Acrivon Q3 net loss narrows to $18.2 mln from $22.4 mln last year * Research and development expenses fell due to fewer milestones and focus on endometrial cancer * Company has $134.4 mln in cash, funding operations into Q2 2027 Outlook * Company expects cash to fund operations into Q2 2027 Result Drivers * Research and development expenses...
Copyright 2023-2026 - www.financetom.com All Rights Reserved